Armonk, NY – DHP Continuous Disinfection Technology Kills Superbugs in Award Winning Hospital Study and Reduces Infection Rates by Up To 70 Percent

Share Article

Dilute Hydrogen Peroxide (DHP), a new and recently patented technology, provides continuous, 24/7/365 environmental disinfection of active hospitals. DHP technology catalytically produces hydrogen peroxide molecules from humidity and oxygen in the air itself and then releases them to the air, where they disinfect germs both in the air, and on all dry surfaces in contact with the air.

Dilute Hydrogen Peroxide (DHP), a new and recently patented technology, provides continuous, 24/7/365 environmental disinfection of active hospitals. DHP technology catalytically produces hydrogen peroxide molecules from humidity and oxygen in the air itself and then releases them to the air, where they disinfect germs both in the air, and on all dry surfaces in contact with the air.

“This is a major breakthrough," stated James D. Lee, P.E., President of Lee Antimicrobial Solutions (LAMS), “It’s automatic. You install it in the ventilation ducts, turn it on, and it starts killing germs on high touch-high use surfaces between cleanings and on every other dry surface that air can reach, even in cracks and crevices where germs hide. More importantly, DHP technology works on dry surfaces that may be missed during cleaning.”

In an award winning study entitled "Dilute Hydrogen Peroxide Technology for Reduction of Microbial Colonization in the Hospital Setting.", presented by Dr. Charles K. Herman at the Association for Professionals in Infection Control (APIC) convention on June 27th, DHP technology demonstrated the capability to eliminate staph, and other contaminating bacteria on a hospital ward within the first week of continuous use. Preliminary data also show an up to 70% reduction in common Hospital Acquired Infection’s over a six month study period in an accredited acute care hospital.

“Aside from its performance, hospitals will also be excited to learn that our technology is less expensive than other infection control systems,” said Douglas Bosma, SVP of R&D at LAMS.

DHP technology is regulated by the EPA under the same category as air purifiers and has been determined to be a non-significant risk technology suitable for continuous use in areas occupied by patients and staff by an Institutional Review Board. Explained Lee, “Our lung enzymes constantly make, use, and regulate hydrogen peroxide as part of our respiratory defense system, and the amount of DHP that we put in the air is hundreds of times less per unit volume than is naturally made and regulated by the enzymes in our own lung moisture.”

DHP technology has been awarded four patents in the US, and nine internationally, with more pending. It is licensed and sold by Lee Antimicrobial Solutions LLC (LAMS) of Armonk, New York; and is available to governmental agencies through LAMS’ licensee, Delafield Solutions, of Huntsville, Alabama.

Lee Antimicrobial Solutions LLC
914-730-1059
430 Bedford Road, Suite 203
Armonk, NY 10504
http://www.leeantimicrobial.com/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

James D Lee
Lee Antimicrobial Solutions
+1 9176581744
Email >
Visit website